Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Rosetta Genomics Revenue
Rosetta Genomics had revenue of $870.00K in the quarter ending June 30, 2017, with 115.35% growth. This brings the company's revenue in the last twelve months to $2.86M, up 106.43% year-over-year. In the year 2016, Rosetta Genomics had annual revenue of $2.04M, down -29.08%.
Revenue (ttm)
2.86M
Revenue Growth
+106.43%
P/S Ratio
0.00
Revenue / Employee
33.24K
Employees
86
Market Cap
593.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | 2.04M | -836.00K | -29.08% |
Dec 31, 2015 | 2.88M | 1.55M | 116.65% |
Dec 31, 2014 | 1.33M | 922.00K | 227.65% |
Dec 31, 2013 | 405.00K | 204.00K | 101.49% |
Dec 31, 2012 | 201.00K | 98.00K | 95.15% |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
SANUWAVE Health | 29.30M |